# DexCom, Inc. (DXCM) stock: price and valuation

URL: https://funkfolio.com/stock/DXCM

> DexCom, Inc. (DXCM) trades at $82.67, is worth $30.83B, is priced at 32.5× earnings and scores 83/100. Valuation, financials and signals.

---

## DexCom, Inc. (DXCM)

DexCom, Inc. (DXCM) is a healthcare company (medical devices) based in the United States. The share price is $82.67, up 1.29% on the day, which values the company at $30.83B. Price as of 17 Nov 2026, 17:42 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $82.67 +1.29% today
- **Market value:** $30.83B
- **P/E ratio:** 32.5× last 12 months
- **Forward P/E:** 26.4×
- **Funk Score:** 83/100
- **Against its own history:** Well below its usual price usual price $199.86
- **200-week average:** $91.14 9% below
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 17:42 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### DexCom, Inc. in more detail

DXCM trades at 32.5× its last twelve months' earnings, 26.4× next year's expected earnings, 6.0× sales. Measured against its own history, the price is 59% below what its usual multiples would imply ($199.86) — well below its usual price. It sits 9% below its 200-week average of $91.14.

Over the last five fiscal years DexCom, Inc. has compounded revenue 19.3% a year, earnings per share 9.5% a year, free cash flow 31.2% a year. Its Funk Score is 83 out of 100 (financial strength 8.3, profitability 8.4, growth 8.7, value 7.7, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score. Worth checking: Gross margin is shrinking.

2 of the superinvestors tracked here hold DXCM, including Baillie Gifford team (1.2% of the portfolio), Jim Simons (1938–2024) (0.3% of the portfolio).

### Superinvestors holding DXCM

2 of the investors tracked here report a position in their latest 13F filing.

- [Baillie Gifford team Baillie Gifford & Co](https://funkfolio.com/gurus/baillie-gifford) 1.18% of portfolio · $1.3B · trimmed · Q3 2026
- [Jim Simons (1938–2024) Renaissance Technologies](https://funkfolio.com/gurus/jim-simons) 0.28% of portfolio · $202.5M · added · Q3 2026

### Health Care companies of similar size

- [Alcon ALC](https://funkfolio.com/stock/ALC)
- [Mettler-Toledo International MTD](https://funkfolio.com/stock/MTD)
- [Centene CNC](https://funkfolio.com/stock/CNC)
- [Genmab GMAB](https://funkfolio.com/stock/GMAB)
- [Illumina ILMN](https://funkfolio.com/stock/ILMN)
- [ResMed RMD](https://funkfolio.com/stock/RMD)
- [Zoetis ZTS](https://funkfolio.com/stock/ZTS)
- [Labcorp Holdings LH](https://funkfolio.com/stock/LH)
- [Koninklijke Philips PHG](https://funkfolio.com/stock/PHG)
- [Roivant Sciences ROIV](https://funkfolio.com/stock/ROIV)
- [West Pharmaceutical Services WST](https://funkfolio.com/stock/WST)
- [Quest Diagnostics DGX](https://funkfolio.com/stock/DGX)

Side by side: [DXCM vs PHG (DexCom, Inc. vs Koninklijke Philips)](https://funkfolio.com/compare/dxcm-vs-phg) [DXCM vs LH (DexCom, Inc. vs Labcorp Holdings)](https://funkfolio.com/compare/dxcm-vs-lh) [DXCM vs ROIV (DexCom, Inc. vs Roivant Sciences)](https://funkfolio.com/compare/dxcm-vs-roiv) [DXCM vs WST (DexCom, Inc. vs West Pharmaceutical Services)](https://funkfolio.com/compare/dxcm-vs-wst) [DXCM vs DGX (DexCom, Inc. vs Quest Diagnostics)](https://funkfolio.com/compare/dgx-vs-dxcm)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### DexCom, Inc. (DXCM): questions and answers

**What is DXCM's P/E ratio?**

DexCom, Inc. trades at 32.5× its last twelve months' earnings and 26.4× next year's expected earnings. At its fiscal year-ends over the past 7 years the P/E ranged from 31.8× to 253.3×, with a median of 95.5×.

**What is DXCM's PEG ratio?**

DexCom, Inc.'s PEG ratio is 1.31 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is DexCom, Inc.'s market cap?**

DexCom, Inc. is valued at $30.83B at a share price of $82.67.

**Is DXCM overvalued or undervalued?**

Against its own history, DXCM is well below its usual price: the price is 59% below the $199.86 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is DXCM above its 200-week moving average?**

No. DXCM is 9.3% below its 200-week average of $91.14. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is DexCom, Inc. growing?**

Over the last five fiscal years DexCom, Inc.'s revenue grew 19.3% a year and its earnings per share 9.5% a year; over ten years revenue grew 27.8% a year.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “DexCom, Inc. (DXCM) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/DXCM

Underlying data: Yahoo Finance; company filings with the SEC.
